FIELD: chemistry.
SUBSTANCE: invention relates to salts of a thiophene compound substituted with α-halogen of general formula (I):
(I), (where R denotes a hydrogen atom or a methoxy group; X is a halogen atom; A is selected from a group consisting of; M is an alkali or alkali-earth metal; and n is 1 when M is an alkali metal, and is 2 when M is an alkali-earth metal).
EFFECT: compound possesses strong LPA receptor antagonist action.
15 cl, 1 tbl, 45 ex
Title | Year | Author | Number |
---|---|---|---|
HALOGEN SUBSTITUTED HETEROCYCLIC COMPOUND | 2013 |
|
RU2649398C2 |
HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND | 2013 |
|
RU2756506C2 |
ANTAGONISTS OF SOMATOSTATIN RECEPTOR SUBTYPE 5 (SSTR5) | 2014 |
|
RU2671958C2 |
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATING SKIN DISEASES | 2009 |
|
RU2544011C2 |
N-(2-CYANO HETEROCYCLYL)PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2669922C2 |
1,2-DI(CYCLO)SUBSTITUTED BENZOLE DERIVATIVES | 2004 |
|
RU2340602C2 |
ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF FOR INHIBITING NOREPINEPHRINE, DOPAMINE AND SEROTONIN REUPTAKE | 2005 |
|
RU2388751C2 |
ARYL-SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS | 2010 |
|
RU2575168C2 |
CYCLOPROPYLAMIDE DERIVATIVES AS N-HISTAMINE RECEPTOR MODULATORS | 2007 |
|
RU2449989C2 |
Authors
Dates
2019-05-27—Published
2015-06-26—Filed